Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.81 USD | -12.56% |
|
-12.56% | -56.90% |
20/05 | Entero Therapeutics, Inc.(NasdaqCM:ENTO) added to NASDAQ Composite Index | CI |
17/05 | First Wave BioPharma, Inc. will Change its Name to Entero Therapeutics, Inc | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-56.90% | 4.48M | |
+34.14% | 51.12B | |
-6.54% | 39.4B | |
+34.92% | 38.48B | |
+12.62% | 26.36B | |
-12.11% | 26.22B | |
-13.43% | 20.96B | |
+43.73% | 14.02B | |
+31.81% | 12.49B | |
-4.54% | 11.61B |
- Stock Market
- Equities
- ENTO Stock
- News Entero Therapeutics, Inc.
- Transcript : AzurRx BioPharma, Inc. Presents at H.C. Wainwright 23rd Annual Global Investment Conference, Sep-13-2021 09